v3.25.3
STOCKHOLDERS' EQUITY (Tables)
 9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense
Three Months Ended
September 30,		Nine Months Ended
September 30,
(in thousands)2025202420252024
Cost of revenue
$6,626 $6,894 $21,737 $20,558 
Selling and marketing
15,009 14,169 45,168 41,621 
Research and development
7,914 7,308 23,789 22,779 
General and administrative
13,492 8,842 30,502 23,260 
$43,041 $37,213 $121,196 $108,218 
Income tax benefit
$(547)$(512)$(1,700)$(1,377)
Schedule of Stock-based Compensation Expense Grants
Nine Months Ended
September 30, 2025
(in thousands)
Quantity
Total Fair Value
Restricted stock units (1)
2,055$82,098 
Non-qualified stock options
3,296 $53,132 
Performance stock options (2)
1,362 $35,324 
Common stock
18$928 
(1) Includes units issued when employees elect to receive 50% of the employee’s target incentive compensation under the Company’s Corporate Incentive Compensation Plan (the “CICP”) in the form of RSUs instead of cash.
(2) Performance stock options allow the holder to purchase a specified number of Common Stock shares at an exercise price equal to or greater than the shares' fair market value at the grant date. The performance stock options granted in the nine months ended September 30, 2025 vest quarterly over two years, beginning after the achievement of specific performance conditions. The options expire ten years from the grant date.